Abstract
AimsClinical guidelines recommend testing both germline and tumour DNA for BRCA1/2 pathogenic variants (PVs) in non-mucinous high-grade epithelial ovarian cancer (NMEOC). In this study, we show that some tumour BRCA1/2...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have